PTP4A1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.773600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.440800E-01
Normal-vs-Stage2
9.275200E-01
Normal-vs-Stage3
3.627200E-01
Normal-vs-Stage4
9.523400E-01
Stage1-vs-Stage2
8.041000E-01
Stage1-vs-Stage3
2.040400E-01
Stage1-vs-Stage4
9.825800E-01
Stage2-vs-Stage3
2.549800E-01
Stage2-vs-Stage4
8.547400E-01
Stage3-vs-Stage4
9.066000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.525400E-01
Normal-vs-AfricanAmerican
5.448200E-01
Normal-vs-Asian
7.688800E-01
Caucasian-vs-AfricanAmerican
9.123800E-02
Caucasian-vs-Asian
8.343000E-01
AfricanAmerican-vs-Asian
1.653420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.401000E-01
Normal-vs-Female
8.032400E-01
Male-vs-Female
5.815800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.623600E-01
Normal-vs-Age(41-60Yrs)
7.240600E-01
Normal-vs-Age(61-80Yrs)
6.348800E-01
Normal-vs-Age(81-100Yrs)
7.326600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.770200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.335000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.098000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.039400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.188200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.514400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.731800E-01
Normal-vs-Daily Drinker
2.762200E-01
Normal-vs-Weekly Drinker
4.187000E-01
Normal-vs-Occasional Drinker
7.446200E-01
Normal-vs-Social Drinker
9.422400E-01
Non Drinker-vs-Daily Drinker
1.027570E-01
Non Drinker-vs-Weekly Drinker
5.073200E-01
Non Drinker-vs-Occasional Drinker
8.741800E-01
Non Drinker-vs-Social Drinker
3.290400E-01
Daily Drinker-vs-Weekly Drinker
3.955800E-01
Daily Drinker-vs-Occasional Drinker
1.148580E-01
Daily Drinker-vs-Social Drinker
2.974000E-02
Weekly Drinker-vs-Occasional Drinker
4.446800E-01
Weekly Drinker-vs-Social Drinker
1.427370E-01
Occasional Drinker-vs-Social Drinker
4.563200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.944400E-01
Normal-vs-Grade 2
2.894000E-01
Normal-vs-Grade 3
2.707000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.645800E-01
Grade 1-vs-Grade 3
7.665800E-01
Grade 1-vs-Grade 4
3.944400E-01
Grade 2-vs-Grade 3
8.534800E-01
Grade 2-vs-Grade 4
2.894000E-01
Grade 3-vs-Grade 4
2.707000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.938800E-01
Normal-vs-NonDiabetic
8.021600E-01
Diabetic-vs-NonDiabetic
5.755800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.704200E-01
Normal-vs-NoPancreatitis
8.230600E-01
Pancreatitis-vs-NoPancreatitis
3.611400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.619600E-01
Normal-vs-N1
9.473600E-01
N0-vs-N1
4.122800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.727600E-01
Normal-vs-TP53-NonMutant
9.009400E-01
TP53-Mutant-vs-TP53-NonMutant
5.765200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
